Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAPS Pilot: Clonidine for Sedation in Ventilated Children
NCT00959062Phase 4Completed
- Sponsor
- Hamilton Health Sciences
- Start
- Jan 2010
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of clonidine in critical illness, sponsored by Hamilton Health Sciences. Primary endpoint: Feasibility of screening procedures at 90 days. Started Jan 2010; status: completed.
02
Drugs
clonidine
03
Conditions
critical illness
Beyond the preview
Go deeper on NCT00959062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00959062.